Evidence map›Paper›PMID 25581551›Full record

ArticleACS chemical neuroscience2015

A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances.

Michael T Nedelcovych, Robert W Gould, Xiaoyan Zhan, Michael Bubser, Xuewen Gong, Michael Grannan, Analisa T Thompson, Magnus Ivarsson, Craig W Lindsley, P Jeffrey Conn and 1 more

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Spontaneous daily sleep disruptions associated with morphine dependence and withdrawal in rats.The Journal of pharmacology and experimental therapeutics · 2025
    Article
  3. Insomnia-related rodent models in drug discovery.Acta pharmacologica Sinica · 2024
    Review
  4. Article
  5. Article
  6. MACS chemical neuroscience · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Partial mGluFrontiers in neuroscience · 2021
    Article
  11. Modulation of arousal and sleep/wake architecture by MNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  12. Phenotypic profiling of mGluGenes, brain, and behavior · 2020
    Article
  13. Sleep in the United States Military.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Michael T Nedelcovych
Robert W Gould
Xiaoyan Zhan
Michael Bubser
Xuewen Gong
Michael Grannan
Analisa T Thompson
Magnus Ivarsson∥Department of Optometry and Vision Sciences, University of Melbourne, Parkville, Victoria 3010, Australia.
Craig W Lindsley§Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States.
P Jeffrey Conn
Carrie K Jones
University of Melbourne · AUVanderbilt University · US

Funding

REGULATION OF SIGNALING BY MGLUR5R01MH062646 · NIMH · VANDERBILT UNIVERSITY · PI P Jeffrey Conn, COLLEEN M NISWENDER · 2001 to 2026
$10.9M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Lead Optimization & Development of Back-Up mGlu5 NAM Candidates for Treatment ofU19MH097056 · NIMH · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2013 to 2015
$3.8M
Functions of Metabotropic Glutamate Receptor SubtypesR37NS031373 · NINDS · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2014 to 2020
$3.5M
M4 Positive Allosteric Modulators for the Treatment of SchizophreniaR01MH086601 · NIMH · VANDERBILT UNIVERSITY · PI JONES, CARRIE KIMBERLY · 2009 to 2013
$1.9M
Postdoctoral Training in CNS Drug Discovery ResearchT32MH093366 · NIMH · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2011 to 2015
$1.0M
NICHD NIH HHS U54 HD083211NIMH NIH HHS MH86601NIMH NIH HHS MH97056NIMH NIH HHS R01 MH062646NIMH NIH HHS R01 MH086601NIMH NIH HHS T32 MH093366NIMH NIH HHS U19 MH097056NINDS NIH HHS R37 NS031373
6 · The paper itself

Abstract

Hyperarousal and sleep disturbances are common, debilitating symptoms of post-traumatic stress disorder (PTSD). PTSD patients also exhibit abnormalities in quantitative electroencephalography (qEEG) power spectra during wake as well as rapid eye movement (REM) and non-REM (NREM) sleep. Selective serotonin reuptake inhibitors (SSRIs), the first-line pharmacological treatment for PTSD, provide modest remediation of the hyperarousal symptoms in PTSD patients, but have little to no effect on the sleep-wake architecture deficits. Development of novel therapeutics for these sleep-wake architecture deficits is limited by a lack of relevant animal models. Thus, the present study investigated whether single prolonged stress (SPS), a rodent model of traumatic stress, induces PTSD-like sleep-wake and qEEG spectral power abnormalities that correlate with changes in central serotonin (5-HT) and neuropeptide Y (NPY) signaling in rats. Rats were implanted with telemetric recording devices to continuously measure EEG before and after SPS treatment. A second cohort of rats was used to measure SPS-induced changes in plasma corticosterone, 5-HT utilization, and NPY expression in brain regions that comprise the neural fear circuitry. SPS caused sustained dysregulation of NREM and REM sleep, accompanied by state-dependent alterations in qEEG power spectra indicative of cortical hyperarousal. These changes corresponded with acute induction of the corticosterone receptor co-chaperone FK506-binding protein 51 and delayed reductions in 5-HT utilization and NPY expression in the amygdala. SPS represents a preclinical model of PTSD-related sleep-wake and qEEG disturbances with underlying alterations in neurotransmitter systems known to modulate both sleep-wake architecture and the neural fear circuitry.

Indexed as

Analysis of VarianceAnimalsBrain WavesCorticosteroneDisease Models, AnimalElectroencephalographyElectromyographyFourier AnalysisIndolesMaleNeuropeptide YRandom AllocationRatsRats, Sprague-DawleyRNA, MessengerSerotoninCorticosteroneindole-3-lactic acidIndolesNeuropeptide YRNA, MessengerSerotoninTacrolimus Binding Proteinselectroencephalography (EEG)FKBP5neuropeptide Y (NPY)post-traumatic stress disorder (PTSD)serotonin (5-HT)Single prolonged stress (SPS)

Identifiers

PMID25581551
PMCPMC4403733
OpenAlexW2320251357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.